The third quarter of 2020 saw a significant rise in the number of acquisitions being made within the healthcare sector, especially compared to Q2. The Coronavirus pandemic caused many disruptions within the healthcare sector in Q2 of this year but there was a comeback in Q3. Here are the top 10 most precedent transactions in the healthcare sector from Q3 of 2020.
Precedent Transactions: Healthcare | Q3 2020Download
Gilead Sciences Acquires Immunomedics, Inc. for $21 billion
On Oct. 23, biopharmaceutical company Gilead Sciences Inc. (NASDAQ: GILD) announced the closing of the acquisition of Immunomedics, Inc. (NASDAQ: IMMU). The deal was worth approximately $21 billion “in the aggregate.” The companies announced the deal on Sept. 13, 2020. On Sept. 24, 2020, Gilead and Maui Merge...
